ClinicalTrials.Veeva

Menu

To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures

Pfizer logo

Pfizer

Status and phase

Completed
Phase 3

Conditions

Seizure Disorder, Partial

Treatments

Drug: Pregabalin

Study type

Interventional

Funder types

Industry

Identifiers

NCT00141388
1008-010

Details and patient eligibility

About

To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.

Enrollment

455 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Must have met the inclusion criteria for the preceding double-blind study
  • Have received double-blind study medication and wish to receive open-label pregabalin.

Exclusion criteria

  • Cannot have absence seizures.

Trial design

Primary purpose

Treatment

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

None (Open label)

Trial contacts and locations

56

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems